The primary structure of the insulin-like growth factor-binding protein (IGFBP) 
INTRODUCTION
The insulin-like growth factors (IGFs) are a family of polypeptides that stimulate cell growth, metab¬ olism, differentiation and mitosis (Froesch, Schmid, Schwander & Zapf, 1985) . IGFs bind to specific binding proteins (IGFBPs) which have been re¬ ported to inhibit (Ross, Francis, Szabo et al. 1989) or stimulate (Elgin, Busby & Clemmons, 1987) IGF-induced DNA synthesis. We have previously reported the purification of an IGFBP from media conditioned by the bovine kidney cell line, MDBK (Szabo, Mottershead, Ballard & Wallace, 1988) . The N-terminal sequence of this binding protein is similar to the acid-stable subunit of the large human serum binding protein (Wood, Cachianes, Henzel et al. 1988) , and to the human amniotic fluid binding protein hIGFBP-1 (Brewer, Stetler, Squires et al. 1988; Brinkman, Groffen, Kortleve et al. 1988; Julkunen, Koistinen, Aalto-Setala et al. 1988; Lee, Hintz, James et al. 1988 ). The binding protein isolated from rat BRL-3A cell-conditioned medium (Mottola, MacDonald, Brackett et al. 1986) shows much greater similarity in size and in Nterminal sequence, suggesting that the MDBK and BRL-3A binding proteins constitute a third class of IGFBPs. Further support for this idea was provided by the distinct binding characteristics of the MDBK binding protein when compared with hIGFBP-1 and hIGFBP-3 in charcoal competition assays. Thus the MDBK binding protein binds preferenti¬ ally to IGF-II and does not bind truncated IGF-I (des(l-3)IGF-I), while hIGFBP-1 binds IGF-I and IGF-II with equal affinity, and hIGFBP-3 has a significant affinity for des(l-3)IGF-I (Forbes, Szabo, Baxter et al. 1988) .
The cDNAs encoding the rat BRL-3A binding protein (Brown, Chiariotti, Orlowski et al. 1989) and its human equivalent (Binkert, Szabo et al. (1988) . Over 300 000 clones were screened in duplicate following the protocol de¬ scribed by Maniatis, Fritsch & Sambrook (1982 Samples were subjected to SDS electrophoresis on 10% (w/v) polyacrylamide gels under nonreducing conditions. The proteins were electroblotted onto nitrocellulose (Sartorius, Gottingen, F.R.G.) after which the nitrocellulose was blocked with 1 % bovine serum albumin and washed three times for 15 min in 0-01 mol sodium phosphate/1 plus 0-15 mol NaCl/1 (pH 7-4; PBS) containing 0-1 % (v/v) Tween 20 (Sigma), before being incubated overnight with the MDBK binding protein antibody. The nitrocellulose filters were washed again three times for 15 min in PBS containing 0-1% Tween 20 before the addition of anti-rabbit IgG-alkaline phosphatase conjugate (Sigma). After a 2-h incuba¬ tion, specific antibody binding was detected with the addition of nitro blue tetrazolium and 5-bromo-4-chloro-3-indoyl phosphate (Bers & Garfin, 1985 The bovine and human forms of IGFBP-2 are longer than the rat form due to four deletions in the rat binding protein (Fig. 4) (Ruoslahti & Pierschbacher, 1987) and may provide an explanation for the observation of an enhanced cellular response of endothelial cells to IGF-I in the presence of human IGFBP-1 (Elgin et al. 1987; Brewer et al. 1988 ). In contrast, we observe that both human IGFBP-1 and bovine IGFBP-2 inhibit the binding of radiolabelled 
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